Introduction And Core Principles

• Flow cytometry is a sophisticated laboratory technique used for immunophenotyping and analyzing the physical and chemical characteristics of cells.
• It relies on passing a suspension of cells through a specialized flow cell where they are interrogated by a laser beam.
• The technique is heavily utilized in hematology and immunology to establish lineage, evaluate cellular maturity, and detect specific protein deficiencies.
• It utilizes specific antibodies conjugated to fluorescent dyes (fluorochromes) that bind to cell surface or intracellular antigens.
• These antigens are commonly referred to as Cluster of Differentiation (CD) markers.

Instrumentation And Light Scatter Mechanics

Hydrodynamic Focusing

• Cells are suspended in a saline solution and surrounded by a sheath fluid.
• Hydrodynamic focusing forces the cells into a single file line, allowing them to pass through the laser beam one by one.

Light Scatter Properties

• When the laser strikes a cell, light is scattered in various directions and picked up by detectors via a dichroic mirror and bandpass filters.
• Forward Scatter (FSC): Measures the light scattered along the same axis as the laser. This parameter correlates directly with the size of the cell.
• Side Scatter (SSC): Measures light scattered at a 90-degree angle. This correlates with the inner complexity and granularity of the cell.

Applications In Malignant Hematology

Diagnosis Of Acute Leukemias

• Acute leukemias are characterized by the accumulation of greater than 20% immature blast cells in the bone marrow.
• Flow cytometry is crucial for defining the precise lineage of these blasts, distinguishing between acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
• It utilizes immaturity markers like CD34 alongside specific lineage markers.

Minimal Residual Disease Monitoring

• Flow cytometry evaluates minimal residual disease (MRD) following induction chemotherapy in acute lymphoblastic leukemia.
• Morphological remission requires less than 5% blasts in the bone marrow.
• Flow cytometry provides a much deeper assessment. A blast percentage less than 0.01% indicates an MRD-negative state, which correlates with a better prognosis.

Lymphoproliferative Disorders

• Flow cytometry helps subtype mature B-cell lymphomas.
• All B-cell lymphomas are positive for CD20.
• Chronic lymphocytic leukemia (CLL) characteristically expresses CD5 and CD23 while being negative for CD10.
• Follicular lymphoma expresses CD10 but is negative for CD5.

Plasma Cell Neoplasms

• Multiparameter flow cytometry assesses plasma cell clonality in multiple myeloma.
• It determines the burden of neoplastic plasma cells in the bone marrow and evaluates light chain restriction (kappa or lambda).

Applications In Non-Malignant Hematology

Paroxysmal Nocturnal Hemoglobinuria

• Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired somatic mutation in hematopoietic stem cells leading to the deficiency of Glycosylphosphatidylinositol (GPI) anchored proteins.
• Flow cytometry is the investigation of choice for confirming PNH.
• It utilizes specific fluorescence-labeled reagents like aerolysin for high sensitivity.
• It detects the absence of CD55 (Decay Accelerating Factor) and CD59 (Membrane Inhibitor of Reactive Lysis) on erythrocytes and leukocytes.
• A finding of greater than 50% neutrophils lacking CD55/CD59 indicates classic PNH.

Applications In Inborn Errors Of Immunity

Lymphocyte Subset Enumeration

• Flow cytometry provides absolute and relative counts of distinct lymphocyte populations.
• It assesses the normal CD4 to CD8 ratio, which is typically 2:1.

Specific Immunodeficiency Diagnostics

• The technique evaluates the presence, absence, or functional competence of specific proteins linked to primary immunodeficiencies.